Cargando…
Long-term management and treatment of acute intermittent porphyria with recurring attacks using pharmacological prophylaxis
BACKGROUND: There is no definitive guidance on whether patients with acute intermittent porphyria (AIP) with recurrent attacks need pharmacological prophylactic treatment. METHODS: The management strategies for patients with frequent (defined as ≥4 annualized attack rate (AAR) and less frequent atta...
Autores principales: | Kuo, Hung-Chou, Ro, Long-Sun, Lin, Chia-Ni, Chen, Hui-Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10697622/ http://dx.doi.org/10.1097/HC9.0000000000000327 |
Ejemplares similares
-
Prophylactic Heme Arginate Infusion for Acute Intermittent Porphyria
por: Kuo, Hung-Chou, et al.
Publicado: (2021) -
Biomarkers that predict attacks of acute intermittent porphyria
por: Takata, Tadayuki, et al.
Publicado: (2022) -
Profiling of Serum Metabolites of Acute Intermittent Porphyria and Asymptomatic HMBS Mutation Carriers
por: Lin, Chia-Ni, et al.
Publicado: (2021) -
Acute Intermittent Porphyria Attack Triggered by COVID-19 Infection
por: Bardak, Ali Emre, et al.
Publicado: (2023) -
A Pharmacological Chaperone Therapy for Acute Intermittent Porphyria
por: Bustad, Helene J., et al.
Publicado: (2020)